PRTA Q1 2025 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+5556.0% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$66M-2319.0% margin

Net Income

-$60M-2128.5% margin

EPS (Diluted)

$-1.12

QoQ Revenue Growth

+33.2%

Cash Flow

Operating Cash Flow

-$53M

Free Cash Flow

-$53M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$495M

Total Liabilities

$58M

Stockholders' Equity

$438M

Cash & Equivalents

$418M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$50,000	+5556.0%
Gross Profit	$3M	$50,000	+5556.0%
Operating Income	-$66M	-$82M	+19.6%
Net Income	-$60M	-$72M	+16.7%

Revenue Segments

Collaboration

$3M98%

License

$50,0002%